Ridgeback Capital Investments L.P.
CIK 1423994 · View on SEC EDGAR ↗
- Portfolio value
- $80.9M
- Positions
- 1
- As of
- June 30, 2026
#8,487 of 9,443 by 13F value · top 89.9%
Portfolio value QoQ: +14341.3% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 1
- Effective number of positions
- 1.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $80,928,962 · sells $0
- New positions
- 1
- Increased
- 0
- Decreased
- 0
- Closed
- 0
On this page
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Healthcare
100.0%
Full portfolio 1 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| REPL Replimune Group, Inc. - Common Stock | $80,928,962 | 100.00% | 7,310,656 | Up ×1 | |||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| REPL | $80,928,962 | 7,310,656 | 100.00% |